Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MN-08 tablets in mild to moderate hypertension
ChiCTR2400092362Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of nitronaphthazine in hypertension (HTN) (2 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: Change from baseline in clinic-measured mean seated diastolic blood pressure. Started Nov 2024; status: recruiting.
02
Drugs
nitronaphthazine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2400092362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092362.